Medip Analytics specializes in developing advanced health economic software for diagnostics to assess the economic impact of healthcare interventions.
We provide easy-to-use software that highlights the value of new healthcare innovations. Our applications analyze their effectiveness, impact on health outcomes, and cost-effectiveness, supporting their journey from development to sales.
We excel in providing precise, data-driven insights for evaluating new diagnostic and prognostic tests in healthcare.
There is a wide variation in the diagnosis and treatment of prostate cancer. Furthermore, costs vary between countries and hospitals, impacting the value of a technology. With our Prostate Platform, companies can calculate and demonstrate the value of their diagnostic or prognostic products within each setting of interest.Learn More
With the rise of lung cancer screening and advancements in early diagnosis, the landscape of lung cancer is rapidly changing. With our Lung Platform, companies can showcase the value of their diagnostic or prognostic products within this evolving setting.Learn More
Tailored to your specific needs, Medip Analytics is able to develop software to show the value of your product in a dynamic way. Our Software can be used to calculate cost-effectiveness or to determine the optimal location for implementing an innovation in the healthcare pathway. We have experience over a wide range of technologies and disease areas.Learn More
At the heart of Medip Analytics lies "HEOR" – Health Economics and Outcomes Research. Utilizing this robust discipline, our strong scientific team, with over 10 years of experience and over 30 scientific publications, creates dynamic comparisons between your medical technology and current standards of care.
Through our simulation models, we envision a dual scenario – one where the current care prevails and another where your technology is used. Drawing from diverse data points including clinical studies, medical guidelines, financial factors, and quality of life indicators, we generate a comprehensive portrayal of your technology's value.
Value of technology depends on the population in which it is used (e.g. low, intermediate and high risk)
Whether the technology is used in a small hospital or major centre might impact its value
How current diagnostic and treatment pathways are defined significantly impacts the value of technology
Amongst other aspects, costs can differ between countries and therewith the country is an important factor in the value assessment
Adjustments to the technology can influence its value. For instance, AI technology is constantly developing and therewith the value is constantly changing
Rising healthcare costs and inflation can affect the value of a new medical innovation when compared to the standard of care
With Medip Analytics, you're not just getting a product, you're gaining a partner committed to your success. A partner who understands that your success is crucial in addressing the global healthcare challenges of today and tomorrow